Atlas Trials

Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis

Clinical trial NCT03452540 · TERMINATED

Trial details

NCT number
NCT03452540
Sponsor
Afimmune
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Acute Decompensated Alcoholic Hepatitis
Start date
2018-11-28
Primary completion
2019-06-19
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.